证券之星消息，1月6日生物制品板块较上一交易日上涨0.55%，辽宁成大领涨。当日上证指数报收于 4083.67，上涨1.5%。深证成指报收于14022.55，上涨1.4%。生物制品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600739 | 辽宁成大 | 12.27 | 7.16% | 53.05万 | 6.33亿 | | 300239 | 东宝生物 | 6.18 | 5.64% | 45.45万 | 2.78亿 | | 616889 | 欧林生物 | 27.66 | 3.83% | 7.44万 | 2.04亿 | | 002773 | 康弘药业 | 33.75 | 2.37% | 24.97万 | 8.38亿 | | 920547 | 无锡晶海 | 24.50 | 2.30% | 7683.33 | 1866.29万 | | 688137 | 近岸蛋白 | 41.66 | 1.36% | 5192.83 | 2149.33万 | | 000661 | 长春高新 | 9 ...

国泰中证畜牧养殖ETF（159865）基金经理为梁杏。 截至发稿，梁杏累计任职时间9年215天，现任基金资产总规模306.17亿元，任职期间最佳基金回报 1112.34%， 任职期间最差基金回报-57.82%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 1月6日，蔚蓝生物涨5.02%，截至发稿，报15.06元/股，成交8138.03万元，换手率2.20%，总市值38.11 亿元。 资料显示，青岛蔚蓝生物股份有限公司位于山东省青岛市崂山区九水东路596-1号，成立日期2005年2月 23日，上市日期2019年1月16日，公司主营业务涉及酶制剂、微生态、动物保健品的研发、生产和销 售。主营业务收入构成为：酶制剂36.63%，动物保健品22.60%，其他业务21.75%，微生态17.27%，其 他(补充)1.76%。 从蔚蓝生物十大流通股东角度 数据显示，国泰基金旗下1只基金位居蔚蓝生物十大流通股东。国泰中证畜牧养殖ETF（159865）三季 度增持67.32万股，持有股 ...

Core Viewpoint - The A-share market showed mixed performance with the Shanghai Composite Index rising over 1% in early trading, indicating positive investor sentiment despite some sector declines [1]. Market Performance - The Shanghai Composite Index closed at 4069.38 points, up 1.14% - The Shenzhen Component Index closed at 13940.24 points, up 0.81% - The ChiNext Index closed at 3293.18 points, down 0.04% [1]. Sector Performance Top Performing Sectors - Insurance sector increased by 4.91% with a total trading volume of 292.22 million hands and a net inflow of 15.55 billion - Small metals sector rose by 4.67% with a trading volume of 954.96 million hands and a net inflow of 37.26 billion - Energy metals sector gained 3.72% with a trading volume of 384.15 million hands and a net inflow of 18.67 billion [2]. Underperforming Sectors - Communication equipment sector decreased by 0.68% with a trading volume of 1889.06 million hands and a net outflow of 77.51 billion - Components sector fell by 0.65% with a trading volume of 929.90 million hands and a net outflow of 31.50 billion - Beauty care sector declined by 0.25% with a trading volume of 157.47 million hands and a net outflow of 0.42 billion [2].

Group 1 - The core point of the article highlights the recent performance of Dongbao Bio, with a stock price increase of 5.13% to 6.15 CNY per share, a trading volume of 97.52 million CNY, a turnover rate of 2.77%, and a total market capitalization of 3.651 billion CNY [1] - Dongbao Bio, established on March 12, 1997, and listed on July 6, 2011, is located in Baotou, Inner Mongolia, and specializes in the research, production, and sales of gelatin products and low molecular weight collagen [1] - The main business revenue composition of Dongbao Bio includes capsule business at 54.13%, gelatin series products and by-products at 37.30%, collagen business at 7.81%, organic fertilizer business at 0.53%, and other supplementary products at 0.22% [1] Group 2 - From the perspective of the top ten circulating shareholders, Guangfa Fund has a fund that ranks among Dongbao Bio's top ten circulating shareholders, specifically Guangfa Jufeng Mixed A (270005), which entered the top ten in the third quarter with 4.5228 million shares, accounting for 0.77% of circulating shares [2] - Guangfa Jufeng Mixed A (270005) was established on December 23, 2005, with a latest scale of 3.366 billion CNY, and has achieved a year-to-date return of 1.2%, ranking 5853 out of 8816 in its category, and a one-year return of 59.59%, ranking 1201 out of 8081 [2]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 成都欧林生物科技股份有限公司（以下简称"公司"）已于2023年12月与科园信海（北京）医疗用品贸 易有限公司（以下简称"科园贸易"）在全国范围内进行公司A群C群脑膜炎球菌多糖结合疫苗（以下简 称"AC结合疫苗"）的市场推广服务达成一致并签署协议。 ● 为持续深化稳定、长期的合作关系，基于双方对市场环境的共同研判，经友好协商，公司与科园贸易 签署了《A群C群脑膜炎球菌多糖结合疫苗市场推广服务协议之补充协议》，对原协议有效期进行优化 调整，其他核心条款保持不变。 ● 对上市公司当期业绩的影响：该协议的签署预计不会对公司当期经营业绩产生重大影响。 ● 合同履行中的重大风险及重大不确定性：本协议约定的推广任务量并不等于实际销量，不构成业绩承 诺，具体的销售情况存在不确定性。本协议受市场环境变化、法律法规等影响，可能存在双方不能继续 履约的风险，公司将根据相关规则的要求及时披露协议进展情况。敬请广大投资者注意相关风险。 一、协议的签署概况 公司已于2023年12月与 ...

Core Viewpoint - JianKai Technology experienced significant trading activity on January 5, with a total of 12 block trades amounting to 550,600 shares and a total transaction value of 41.90 million yuan, reflecting a discount of 17.17% compared to the closing price of the day [2][3] Trading Activity Summary - The stock's closing price on January 5 was 91.88 yuan, marking an increase of 11.78% with a turnover rate of 3.71% and a total trading volume of 201 million yuan, while there was a net outflow of 711,900 yuan in main funds [2] - Over the past five days, the stock has risen by 11.44%, with a total net inflow of 2.36 million yuan [2] - In the last three months, there have been 31 block trades for the stock, with a cumulative transaction value of 91.63 million yuan [2] Margin Trading Data - The latest margin financing balance for the stock is 172 million yuan, which has increased by 3.52 million yuan over the past five days, representing a growth rate of 2.08% [2]

证券日报网讯1月5日，沃森生物（300142）在互动平台回答投资者提问时表示，公司在国际市场上将不 断加强与全球健康组织和海外生物药企的交流与合作，采取多元化合作模式，持续深入推进产品在海外 市场的注册和出口，加快海外本地化产业项目的建设，为公司和股东创造价值。关于公司国际业务的开 展情况及相关产品的研发进展情况请持续关注公司披露的相关公告。 ...

（编辑 丛可心） 证券日报网讯 1月5日，沃森生物在互动平台回答投资者提问时表示，公司在国际市场上将不断加强与 全球健康组织和海外生物药企的交流与合作，采取多元化合作模式，持续深入推进产品在海外市场的注 册和出口，加快海外本地化产业项目的建设，为公司和股东创造价值。 ...

每经头条（nbdtoutiao）——秒光！1499元飞天茅台上线即空，i茅台App冲上苹果购物榜第一，10万用 户已下单！经销商同价做回馈，1000箱很快卖完 每经AI快讯，艾德生物1月5日晚间发布公告称，截至2025年12月31日，公司通过回购专用证券账户以 集中竞价交易方式实施回购股份约41万股，占公司目前总股本的0.1%，回购股份的最高成交价为21.97 元/股，最低成交价为20.5元/股，支付的总金额约为861万元。 （记者 曾健辉） ...

从资金流向上来看，当日生物制品板块主力资金净流入1.91亿元，游资资金净流出2.73亿元，散户资金净 流入8203.94万元。生物制品板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入(元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 002773 康弘药业 | | 1.18 Z | 18.31% | -3021.77万 | -4.70% | -8748.13万 | -13.61% | | 000661 | 长春高新 | 7444.34万 | 9.43% | -4755.38万 | -6.02% | -2688.95万 | -3.40% | | 688331 荣昌生物 | | 6982.31万 | 10.14% | -2366.87万 | -3.44% | -4615.43万 | -6.71% | | 300122 智飞生物 | | 3724.35万 | 9.83% | 85.58万 | 0.23% | -3809.93万 | -10.05% ...